ABC
UTHR icon

Associated Banc-Corp’s United Therapeutics UTHR Stock Holding History

Associated Banc-Corp’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25
Closed -$4K – 858
2020
Q4 		$4K Hold
25
– – ﹤0.01% 581
2020
Q3 		$3K Hold
25
– – ﹤0.01% 593
2020
Q2 		$3K Hold
25
– – ﹤0.01% 563
2020
Q1 		$2K Buy
+25
New +$2.38K ﹤0.01% 692

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Associated Banc-Corp's UTHR Position: Q1 2021 in Review

Associated Banc-Corp sold out of United Therapeutics (UTHR) in Q1 2021, closing a stake of 25 shares — an estimated $4K sold.

Associated Banc-Corp first reported a position in UTHR in Q1 2020 and held it in 4 quarters. The position peaked at $4K in Q4 2020. 391 funds tracked by Wall St. Rank hold UTHR as of Q1 2021.

  • Associated Banc-Corp reported no remaining United Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 25 United Therapeutics shares in Q1 2021, an estimated $4K.
  • Associated Banc-Corp first reported a position in United Therapeutics in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's United Therapeutics position peaked at $4K in Q4 2020.
  • 391 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.